Genomics Forges Ahead in the Sequencing-Based Biotech Sector
"Commercial Times, Wei I Chuan
Established in 2001, Genomics has been actively leading Taiwan's genetic sequencing service market. With a comprehensive range of sequencing systems, it surpasses its competitors significantly, emerging as Taiwan's largest commercial genomic sequencing company. Drawing on its extensive expertise in fundamental research, the company has diversified into clinical applications, particularly focusing on precision medicine in women's and children's health, along with cancer gene testing."
APR.18
2018
2018
Precision Medicine Industry's “Three Full-Range Coverage”: Genomics to Offer
"“Fully Leading”, “Comprehensive Services”, “Whole-Person Testing”
Precision Medicine Industry's “Three Full-Range Coverage”: Genomics to Offer
By Li Hu Men
The concept of precision medicine is sweeping across the globe. With over 17 years in the industry, Genomics leverages its accumulated research and development capabilities to heavily invest in major disease and functional medical testing projects. They have introduced the world's most advanced gene sequencing instrument, the NovaSeq 6000, aiming to initiate Taiwan's precision services in line with international technology standards."
MAR.16
2018
2018
